68Ga PSMA-HBED-CC PET in Patients With Biochemical Recurrence
Latest Information Update: 19 Jul 2024
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 28 Jun 2024 Status changed from active, no longer recruiting to completed.
- 21 May 2021 Planned primary completion date changed from 31 Dec 2020 to 31 Dec 2021.
- 11 Mar 2019 Status changed from recruiting to active, no longer recruiting.